<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166359">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01730898</url>
  </required_header>
  <id_info>
    <org_study_id>BL14</org_study_id>
    <nct_id>NCT01730898</nct_id>
  </id_info>
  <brief_title>Lutein Absorption in Healthy Adults</brief_title>
  <official_title>Lutein Absorption in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the absorption of lutein when consumed in different oil blends.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Plasma lutein</measure>
    <time_frame>baseline and 336 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>adjusted area under the curve at specified postprandial timepoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma carotenoids</measure>
    <time_frame>2, 4, 6, 8, 12, 24, 48, and 336 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>mean concentrations at specified postprandial timepoints</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma lipid concentrations</measure>
    <time_frame>baseline and 48 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>averaged concentrations at specified postprandial timepoints</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Control capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study product containing lutein</intervention_name>
    <description>delivered in capsule form</description>
    <arm_group_label>Control capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study product containing lutein</intervention_name>
    <description>delivered in capsule form</description>
    <arm_group_label>Experimental capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects will be eligible for the study if they meet all of the following inclusion
        criteria:

          -  BMI ≥ 18 and ≤ 25 kg/m2

          -  Between 18 and 45 years of age, inclusive

          -  Male or a non-pregnant, non-lactating female, nulliparous or at least 6 weeks
             postpartum prior to screening visit.  A urine pregnancy test is required for all
             female subjects unless she is not of childbearing potential.  If female is of
             childbearing potential, is practicing one of the following methods of birth control
             (and will continue through the duration of the study):

               -  Condoms, sponge, diaphragm or intrauterine device;

               -  Oral or parenteral contraceptives for 3 months prior to screening visit;

               -  Vasectomized partner;

               -  Total abstinence from sexual intercourse.

          -  If on a chronic medication, subject has been on constant dosage for at least two
             months prior to screening visit

        Exclusion Criteria:

        Subjects will be excluded from the study if they meet any of the following criteria:

          -  Current smoker

          -  Current chronic disease, including malabsorption or gastrointestinal disorders;
             hyperlipidemia; anemia; hemophilia; excessive bleeding; cystic fibrosis; kidney
             disease requiring dialysis; diabetes; active malignancy; wasting condition

          -  Current chronic contagious, infectious disease, such as active tuberculosis,
             Hepatitis B or C,or HIV

          -  Vegetarian, or has very selective food habits/dieting

          -  Average intake of alcoholic beverages greater than 2 drinks per day

          -  Medication or dietary supplement use to lower plasma lipids or affect lipid
             absorption or transport, including antibiotics

          -  Supplement use that contains carotenoids (multi-vitamin as an example)

          -  Known allergy or intolerance to any ingredient found in the study products
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Williams</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Biofortis Clinical Research</name>
      <address>
        <city>Addison</city>
        <state>Illinois</state>
        <zip>60101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 2, 2013</lastchanged_date>
  <firstreceived_date>November 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
